Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Imaging, Cine | 80 | 2024 | 1050 | 6.040 |
Why?
|
Coronary Circulation | 72 | 2024 | 1569 | 5.690 |
Why?
|
Myocardium | 65 | 2024 | 4725 | 5.200 |
Why?
|
Myocardial Perfusion Imaging | 30 | 2023 | 575 | 4.560 |
Why?
|
Ventricular Remodeling | 36 | 2024 | 1267 | 4.080 |
Why?
|
Gadolinium DTPA | 41 | 2019 | 823 | 2.850 |
Why?
|
Contrast Media | 73 | 2023 | 5307 | 2.720 |
Why?
|
Magnetic Resonance Imaging | 131 | 2024 | 36426 | 2.610 |
Why?
|
Ventricular Function, Left | 57 | 2024 | 3879 | 2.200 |
Why?
|
Cardiomyopathies | 21 | 2024 | 1964 | 2.160 |
Why?
|
Heart | 25 | 2024 | 4404 | 1.920 |
Why?
|
Heart Diseases | 14 | 2023 | 2781 | 1.830 |
Why?
|
Fractional Flow Reserve, Myocardial | 9 | 2022 | 323 | 1.750 |
Why?
|
Gadolinium | 22 | 2023 | 960 | 1.680 |
Why?
|
Magnetic Resonance Angiography | 24 | 2017 | 1432 | 1.540 |
Why?
|
Fibrosis | 34 | 2024 | 2049 | 1.500 |
Why?
|
Myocardial Ischemia | 26 | 2023 | 2113 | 1.490 |
Why?
|
Coronary Artery Disease | 29 | 2023 | 6403 | 1.300 |
Why?
|
Stroke Volume | 47 | 2024 | 5496 | 1.260 |
Why?
|
Heart Ventricles | 25 | 2024 | 3807 | 1.230 |
Why?
|
Predictive Value of Tests | 63 | 2024 | 15266 | 1.200 |
Why?
|
Aortic Valve Stenosis | 12 | 2024 | 2001 | 1.090 |
Why?
|
Hyperemia | 10 | 2013 | 221 | 1.080 |
Why?
|
Hypertrophy, Left Ventricular | 10 | 2021 | 851 | 1.070 |
Why?
|
Cardiomyopathy, Hypertrophic | 14 | 2022 | 1310 | 1.040 |
Why?
|
Cardiovascular System | 2 | 2023 | 834 | 1.010 |
Why?
|
Image Enhancement | 25 | 2021 | 2884 | 0.950 |
Why?
|
Myocardial Infarction | 24 | 2024 | 11461 | 0.860 |
Why?
|
Cardiomyopathy, Dilated | 4 | 2019 | 829 | 0.820 |
Why?
|
Cardiac Imaging Techniques | 6 | 2021 | 267 | 0.810 |
Why?
|
Anthracyclines | 4 | 2023 | 284 | 0.800 |
Why?
|
Coronary Stenosis | 10 | 2016 | 794 | 0.780 |
Why?
|
Pericardium | 5 | 2018 | 675 | 0.760 |
Why?
|
Image Interpretation, Computer-Assisted | 18 | 2019 | 3359 | 0.750 |
Why?
|
Ventricular Dysfunction, Left | 15 | 2019 | 2118 | 0.740 |
Why?
|
Exercise Test | 17 | 2024 | 2127 | 0.720 |
Why?
|
Transposition of Great Vessels | 4 | 2018 | 581 | 0.720 |
Why?
|
Myocytes, Cardiac | 6 | 2018 | 1668 | 0.710 |
Why?
|
Heart Failure | 19 | 2024 | 11671 | 0.700 |
Why?
|
Atherosclerosis | 18 | 2024 | 3407 | 0.690 |
Why?
|
Aorta, Thoracic | 8 | 2016 | 1096 | 0.680 |
Why?
|
Coronary Angiography | 24 | 2020 | 4471 | 0.680 |
Why?
|
Ventricular Dysfunction, Right | 3 | 2024 | 628 | 0.660 |
Why?
|
Ventricular Dysfunction | 4 | 2021 | 144 | 0.660 |
Why?
|
Magnetic Resonance Spectroscopy | 13 | 2023 | 3769 | 0.650 |
Why?
|
Ethylene Glycols | 4 | 2024 | 190 | 0.620 |
Why?
|
Amyloidosis | 5 | 2021 | 817 | 0.620 |
Why?
|
Spironolactone | 3 | 2023 | 412 | 0.620 |
Why?
|
Myocardial Contraction | 11 | 2014 | 1515 | 0.600 |
Why?
|
Myocarditis | 6 | 2022 | 788 | 0.590 |
Why?
|
Echocardiography, Doppler | 8 | 2021 | 897 | 0.590 |
Why?
|
Perfusion | 9 | 2023 | 1373 | 0.590 |
Why?
|
Microcirculation | 9 | 2021 | 1272 | 0.580 |
Why?
|
Humans | 256 | 2024 | 761596 | 0.580 |
Why?
|
Coronary Disease | 18 | 2009 | 5914 | 0.570 |
Why?
|
Tetralogy of Fallot | 4 | 2019 | 618 | 0.570 |
Why?
|
Hypertension | 8 | 2024 | 8540 | 0.540 |
Why?
|
Coronary Vessels | 11 | 2018 | 3096 | 0.530 |
Why?
|
Image Processing, Computer-Assisted | 28 | 2021 | 9001 | 0.530 |
Why?
|
Immunoglobulin Light Chains | 3 | 2024 | 285 | 0.530 |
Why?
|
Fatty Liver | 3 | 2017 | 790 | 0.520 |
Why?
|
Organometallic Compounds | 11 | 2019 | 647 | 0.510 |
Why?
|
Atrial Function, Left | 6 | 2018 | 185 | 0.510 |
Why?
|
Vasodilator Agents | 9 | 2014 | 973 | 0.510 |
Why?
|
Extracellular Matrix | 5 | 2017 | 1726 | 0.500 |
Why?
|
Exercise Tolerance | 7 | 2024 | 836 | 0.500 |
Why?
|
Regional Blood Flow | 12 | 2019 | 1496 | 0.490 |
Why?
|
Cardiomegaly | 2 | 2016 | 590 | 0.490 |
Why?
|
Body Water | 2 | 2013 | 340 | 0.480 |
Why?
|
Middle Aged | 130 | 2024 | 220921 | 0.480 |
Why?
|
Receptors, Mineralocorticoid | 2 | 2024 | 163 | 0.480 |
Why?
|
Male | 165 | 2024 | 360846 | 0.480 |
Why?
|
Prognosis | 42 | 2024 | 29629 | 0.460 |
Why?
|
Aniline Compounds | 4 | 2024 | 1069 | 0.460 |
Why?
|
Microspheres | 7 | 2012 | 784 | 0.450 |
Why?
|
Adenosine | 8 | 2015 | 808 | 0.450 |
Why?
|
Microvascular Angina | 4 | 2018 | 14 | 0.440 |
Why?
|
Female | 161 | 2024 | 392705 | 0.440 |
Why?
|
Fatty Acids, Omega-3 | 5 | 2024 | 1390 | 0.440 |
Why?
|
Tachycardia, Ventricular | 3 | 2023 | 1304 | 0.430 |
Why?
|
Amyloid | 2 | 2018 | 841 | 0.420 |
Why?
|
Endomyocardial Fibrosis | 1 | 2012 | 41 | 0.420 |
Why?
|
Adiposity | 4 | 2017 | 1879 | 0.420 |
Why?
|
Aged | 101 | 2024 | 169310 | 0.420 |
Why?
|
Ventricular Fibrillation | 1 | 2015 | 537 | 0.410 |
Why?
|
Artificial Intelligence | 5 | 2022 | 2578 | 0.410 |
Why?
|
Ventriculography, First-Pass | 4 | 2013 | 20 | 0.400 |
Why?
|
Prealbumin | 1 | 2014 | 222 | 0.400 |
Why?
|
Tomography, X-Ray Computed | 17 | 2019 | 20568 | 0.400 |
Why?
|
Atrial Fibrillation | 11 | 2024 | 5127 | 0.400 |
Why?
|
Heart Atria | 7 | 2021 | 1345 | 0.400 |
Why?
|
Hypoplastic Left Heart Syndrome | 5 | 2021 | 594 | 0.400 |
Why?
|
Prospective Studies | 48 | 2024 | 54423 | 0.390 |
Why?
|
Sensitivity and Specificity | 30 | 2014 | 14665 | 0.390 |
Why?
|
Models, Cardiovascular | 9 | 2009 | 981 | 0.380 |
Why?
|
Amyloid Neuropathies, Familial | 1 | 2014 | 151 | 0.380 |
Why?
|
Blood Flow Velocity | 8 | 2019 | 1371 | 0.370 |
Why?
|
Sarcomeres | 3 | 2021 | 368 | 0.370 |
Why?
|
Reproducibility of Results | 27 | 2022 | 20100 | 0.370 |
Why?
|
Oxygen Consumption | 7 | 2019 | 1866 | 0.370 |
Why?
|
Collateral Circulation | 4 | 2007 | 294 | 0.360 |
Why?
|
Phenotype | 8 | 2024 | 16592 | 0.360 |
Why?
|
Coronary Artery Bypass | 3 | 2022 | 2188 | 0.350 |
Why?
|
Iron | 2 | 2015 | 1793 | 0.350 |
Why?
|
Tissue Survival | 3 | 2008 | 119 | 0.350 |
Why?
|
Adipose Tissue | 3 | 2017 | 3313 | 0.350 |
Why?
|
Imaging, Three-Dimensional | 10 | 2016 | 4062 | 0.340 |
Why?
|
Capillary Permeability | 2 | 2014 | 773 | 0.340 |
Why?
|
Edema | 1 | 2014 | 766 | 0.340 |
Why?
|
Ventricular Function, Right | 7 | 2019 | 617 | 0.340 |
Why?
|
Linear Models | 16 | 2017 | 5872 | 0.330 |
Why?
|
Death, Sudden, Cardiac | 6 | 2023 | 1555 | 0.320 |
Why?
|
Swine | 17 | 2014 | 5915 | 0.310 |
Why?
|
Time Factors | 32 | 2024 | 39969 | 0.310 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2009 | 101 | 0.310 |
Why?
|
Systole | 11 | 2016 | 936 | 0.310 |
Why?
|
Aorta | 5 | 2020 | 2041 | 0.310 |
Why?
|
Myocardial Reperfusion | 4 | 2021 | 338 | 0.310 |
Why?
|
Heart Defects, Congenital | 10 | 2019 | 4671 | 0.300 |
Why?
|
Radiopharmaceuticals | 6 | 2024 | 2650 | 0.300 |
Why?
|
Cardiac Surgical Procedures | 4 | 2016 | 3627 | 0.300 |
Why?
|
Tomography | 2 | 2019 | 411 | 0.290 |
Why?
|
Obesity | 6 | 2016 | 12947 | 0.290 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2023 | 678 | 0.280 |
Why?
|
Retinal Artery | 1 | 2007 | 109 | 0.280 |
Why?
|
Risk Factors | 42 | 2024 | 74213 | 0.280 |
Why?
|
Electrocardiography | 15 | 2017 | 6377 | 0.280 |
Why?
|
Microvessels | 3 | 2018 | 577 | 0.280 |
Why?
|
Adult | 72 | 2024 | 221210 | 0.280 |
Why?
|
Meglumine | 5 | 2019 | 144 | 0.280 |
Why?
|
Natriuretic Peptide, Brain | 5 | 2024 | 1723 | 0.270 |
Why?
|
Sports | 2 | 2022 | 705 | 0.270 |
Why?
|
Pulmonary Veins | 4 | 2014 | 743 | 0.260 |
Why?
|
Cardiovascular Diseases | 13 | 2021 | 15502 | 0.260 |
Why?
|
Heart Transplantation | 7 | 2024 | 3233 | 0.260 |
Why?
|
Arrhythmias, Cardiac | 7 | 2023 | 2244 | 0.240 |
Why?
|
Reference Values | 12 | 2020 | 4920 | 0.240 |
Why?
|
Insulin Resistance | 3 | 2019 | 3964 | 0.240 |
Why?
|
Echocardiography | 17 | 2024 | 4989 | 0.230 |
Why?
|
Myocardial Revascularization | 4 | 2005 | 790 | 0.230 |
Why?
|
Embolism, Air | 1 | 2004 | 110 | 0.230 |
Why?
|
Age Factors | 12 | 2020 | 18399 | 0.230 |
Why?
|
Cardiac Output, Low | 1 | 2004 | 191 | 0.230 |
Why?
|
Case-Control Studies | 20 | 2021 | 22176 | 0.220 |
Why?
|
NG-Nitroarginine Methyl Ester | 2 | 2014 | 260 | 0.220 |
Why?
|
Aging | 4 | 2020 | 8710 | 0.210 |
Why?
|
Peptide Fragments | 5 | 2024 | 5112 | 0.210 |
Why?
|
Weight Loss | 1 | 2014 | 2684 | 0.210 |
Why?
|
Follow-Up Studies | 25 | 2023 | 39106 | 0.200 |
Why?
|
Liver | 2 | 2019 | 7528 | 0.200 |
Why?
|
Catheter Ablation | 6 | 2021 | 2751 | 0.200 |
Why?
|
Arteritis | 1 | 2024 | 158 | 0.200 |
Why?
|
Disease Models, Animal | 10 | 2016 | 18255 | 0.190 |
Why?
|
Chi-Square Distribution | 7 | 2017 | 3415 | 0.190 |
Why?
|
Radiographic Image Enhancement | 3 | 2007 | 876 | 0.190 |
Why?
|
Algorithms | 9 | 2014 | 14033 | 0.190 |
Why?
|
Sympathetic Nervous System | 1 | 2024 | 518 | 0.190 |
Why?
|
Risk Assessment | 17 | 2024 | 23996 | 0.190 |
Why?
|
Extracellular Space | 3 | 2013 | 563 | 0.180 |
Why?
|
Edema, Cardiac | 2 | 2017 | 19 | 0.180 |
Why?
|
Doxorubicin | 2 | 2018 | 2224 | 0.180 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 4 | 2010 | 1068 | 0.180 |
Why?
|
Friedreich Ataxia | 1 | 2021 | 77 | 0.180 |
Why?
|
Cicatrix | 3 | 2022 | 798 | 0.170 |
Why?
|
Collagen | 2 | 2013 | 2638 | 0.170 |
Why?
|
Diastole | 6 | 2014 | 782 | 0.170 |
Why?
|
Benzylamines | 1 | 2020 | 247 | 0.170 |
Why?
|
Young Adult | 22 | 2023 | 59260 | 0.170 |
Why?
|
Molecular Imaging | 2 | 2023 | 815 | 0.170 |
Why?
|
Severity of Illness Index | 16 | 2024 | 15843 | 0.160 |
Why?
|
Fatty Acid Desaturases | 1 | 2019 | 100 | 0.160 |
Why?
|
Uracil | 1 | 2020 | 207 | 0.160 |
Why?
|
Animals | 34 | 2020 | 168475 | 0.160 |
Why?
|
Aged, 80 and over | 24 | 2022 | 58984 | 0.160 |
Why?
|
HIV Infections | 5 | 2024 | 17354 | 0.160 |
Why?
|
Artifacts | 5 | 2010 | 1911 | 0.160 |
Why?
|
Pulmonary Artery | 3 | 2017 | 1927 | 0.160 |
Why?
|
Stem Cell Transplantation | 2 | 2004 | 1600 | 0.160 |
Why?
|
Treatment Outcome | 21 | 2024 | 64685 | 0.150 |
Why?
|
Positron-Emission Tomography | 5 | 2019 | 6484 | 0.150 |
Why?
|
Elasticity | 5 | 2015 | 655 | 0.150 |
Why?
|
Cardiovascular Agents | 2 | 2023 | 840 | 0.150 |
Why?
|
Intra-Abdominal Fat | 4 | 2015 | 613 | 0.150 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2021 | 12149 | 0.150 |
Why?
|
Cardiac Volume | 3 | 2013 | 197 | 0.140 |
Why?
|
Oxygen | 3 | 2021 | 4227 | 0.140 |
Why?
|
Fluorine Radioisotopes | 1 | 2020 | 418 | 0.140 |
Why?
|
American Heart Association | 3 | 2022 | 1039 | 0.140 |
Why?
|
Proportional Hazards Models | 10 | 2017 | 12463 | 0.140 |
Why?
|
Hemodynamics | 12 | 2016 | 4160 | 0.140 |
Why?
|
Body Surface Potential Mapping | 1 | 2018 | 228 | 0.140 |
Why?
|
Observer Variation | 5 | 2013 | 2606 | 0.140 |
Why?
|
HIV | 2 | 2023 | 1582 | 0.140 |
Why?
|
Mitral Valve Prolapse | 1 | 2018 | 212 | 0.140 |
Why?
|
Electric Impedance | 1 | 2001 | 757 | 0.130 |
Why?
|
Adiponectin | 2 | 2019 | 1113 | 0.130 |
Why?
|
Chagas Cardiomyopathy | 1 | 2016 | 71 | 0.130 |
Why?
|
Aortic Coarctation | 2 | 2016 | 275 | 0.130 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2017 | 277 | 0.130 |
Why?
|
Sex Factors | 8 | 2017 | 10554 | 0.130 |
Why?
|
Diagnostic Imaging | 3 | 2012 | 3530 | 0.130 |
Why?
|
Cardiac-Gated Imaging Techniques | 2 | 2014 | 139 | 0.130 |
Why?
|
Carotid Artery, Common | 1 | 2016 | 175 | 0.130 |
Why?
|
Aortic Valve | 2 | 2024 | 1955 | 0.130 |
Why?
|
Vena Cava, Inferior | 1 | 2019 | 458 | 0.130 |
Why?
|
Norwood Procedures | 1 | 2017 | 192 | 0.130 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 3 | 2022 | 322 | 0.130 |
Why?
|
Oxides | 1 | 1997 | 401 | 0.130 |
Why?
|
Pilot Projects | 9 | 2024 | 8633 | 0.130 |
Why?
|
Disease Progression | 10 | 2019 | 13510 | 0.120 |
Why?
|
Computer Simulation | 5 | 2009 | 6241 | 0.120 |
Why?
|
Pulmonary Circulation | 1 | 2017 | 737 | 0.120 |
Why?
|
Pentetic Acid | 6 | 1997 | 209 | 0.120 |
Why?
|
Monocytes | 2 | 2022 | 2570 | 0.120 |
Why?
|
Magnetic Resonance Imaging, Interventional | 2 | 2014 | 187 | 0.120 |
Why?
|
United States | 18 | 2022 | 72340 | 0.120 |
Why?
|
Fish Oils | 1 | 2018 | 483 | 0.120 |
Why?
|
Body Fat Distribution | 1 | 2015 | 245 | 0.120 |
Why?
|
Bone Marrow Cells | 1 | 2022 | 2417 | 0.120 |
Why?
|
Lymphoma | 1 | 2023 | 1901 | 0.110 |
Why?
|
Leptin | 2 | 2019 | 1597 | 0.110 |
Why?
|
Fontan Procedure | 3 | 2019 | 796 | 0.110 |
Why?
|
Multivariate Analysis | 7 | 2015 | 12059 | 0.110 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2024 | 1553 | 0.110 |
Why?
|
Abdominal Fat | 1 | 2015 | 221 | 0.110 |
Why?
|
Albuminuria | 2 | 2015 | 658 | 0.110 |
Why?
|
Longitudinal Studies | 5 | 2017 | 14608 | 0.110 |
Why?
|
Myocardial Reperfusion Injury | 1 | 1997 | 481 | 0.110 |
Why?
|
Asymptomatic Diseases | 4 | 2019 | 588 | 0.110 |
Why?
|
Random Allocation | 4 | 2013 | 2395 | 0.110 |
Why?
|
Dogs | 9 | 2008 | 3839 | 0.110 |
Why?
|
Organ Size | 6 | 2016 | 2254 | 0.110 |
Why?
|
Fibroblasts | 1 | 2023 | 4142 | 0.110 |
Why?
|
Incidence | 9 | 2017 | 21355 | 0.110 |
Why?
|
Chest Pain | 1 | 2020 | 1091 | 0.110 |
Why?
|
Endocardium | 2 | 2011 | 248 | 0.110 |
Why?
|
Diabetic Angiopathies | 2 | 2017 | 803 | 0.110 |
Why?
|
Porosity | 1 | 1994 | 349 | 0.110 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5841 | 0.110 |
Why?
|
Adolescent | 22 | 2020 | 88326 | 0.100 |
Why?
|
Triglycerides | 3 | 2016 | 2461 | 0.100 |
Why?
|
Heart Rate | 3 | 2019 | 4195 | 0.100 |
Why?
|
Papillary Muscles | 2 | 2018 | 192 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2020 | 1161 | 0.100 |
Why?
|
Echocardiography, Three-Dimensional | 2 | 2008 | 607 | 0.100 |
Why?
|
Obesity, Abdominal | 1 | 2015 | 374 | 0.100 |
Why?
|
Stress, Physiological | 1 | 2019 | 1403 | 0.100 |
Why?
|
Waist-Hip Ratio | 1 | 2013 | 518 | 0.100 |
Why?
|
Retrospective Studies | 19 | 2023 | 80647 | 0.100 |
Why?
|
Ferrosoferric Oxide | 2 | 2007 | 348 | 0.100 |
Why?
|
Hypertrophy | 1 | 2013 | 561 | 0.090 |
Why?
|
Cell Size | 1 | 2013 | 624 | 0.090 |
Why?
|
Child | 17 | 2023 | 80158 | 0.090 |
Why?
|
Body Mass Index | 9 | 2016 | 12953 | 0.090 |
Why?
|
Cross-Sectional Studies | 14 | 2022 | 26129 | 0.090 |
Why?
|
Physical Fitness | 1 | 2016 | 743 | 0.090 |
Why?
|
Injections, Intravenous | 4 | 2018 | 1379 | 0.090 |
Why?
|
Blood Pressure | 7 | 2020 | 8481 | 0.090 |
Why?
|
Acute Coronary Syndrome | 1 | 2024 | 2190 | 0.090 |
Why?
|
Vascular Resistance | 2 | 2015 | 930 | 0.090 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2013 | 261 | 0.090 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2008 | 1725 | 0.090 |
Why?
|
C-Reactive Protein | 4 | 2015 | 3826 | 0.090 |
Why?
|
Rheology | 2 | 2009 | 347 | 0.090 |
Why?
|
Carotid Arteries | 1 | 2014 | 941 | 0.090 |
Why?
|
Foundations | 1 | 2010 | 95 | 0.090 |
Why?
|
Registries | 4 | 2022 | 8225 | 0.090 |
Why?
|
Child, Preschool | 13 | 2021 | 42232 | 0.080 |
Why?
|
Feasibility Studies | 7 | 2014 | 5247 | 0.080 |
Why?
|
Analysis of Variance | 4 | 2013 | 6228 | 0.080 |
Why?
|
Mutation | 4 | 2017 | 30053 | 0.080 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2010 | 97 | 0.080 |
Why?
|
Postoperative Care | 1 | 2016 | 1468 | 0.080 |
Why?
|
Phantoms, Imaging | 3 | 2022 | 2526 | 0.080 |
Why?
|
Smoking | 5 | 2012 | 9053 | 0.080 |
Why?
|
Spinal Canal | 1 | 2009 | 41 | 0.080 |
Why?
|
Tricuspid Valve | 2 | 2009 | 410 | 0.080 |
Why?
|
Health Status Disparities | 2 | 2017 | 1853 | 0.080 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2015 | 696 | 0.080 |
Why?
|
England | 3 | 2017 | 526 | 0.080 |
Why?
|
Diet, Mediterranean | 1 | 2015 | 740 | 0.080 |
Why?
|
Radiology | 1 | 2022 | 2113 | 0.080 |
Why?
|
Mitral Valve Insufficiency | 1 | 2018 | 1400 | 0.080 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2013 | 575 | 0.080 |
Why?
|
Heart Function Tests | 1 | 2009 | 318 | 0.080 |
Why?
|
Neovascularization, Physiologic | 3 | 2006 | 1349 | 0.080 |
Why?
|
Aldosterone | 1 | 2013 | 870 | 0.080 |
Why?
|
Echocardiography, Four-Dimensional | 1 | 2007 | 14 | 0.080 |
Why?
|
Double-Blind Method | 5 | 2023 | 12341 | 0.070 |
Why?
|
Inflammation Mediators | 2 | 2014 | 1886 | 0.070 |
Why?
|
Subtraction Technique | 1 | 2010 | 512 | 0.070 |
Why?
|
Mice | 5 | 2020 | 81539 | 0.070 |
Why?
|
Prevalence | 7 | 2022 | 15733 | 0.070 |
Why?
|
Radioisotopes | 1 | 2008 | 499 | 0.070 |
Why?
|
Pulsatile Flow | 1 | 2008 | 321 | 0.070 |
Why?
|
Vascular Surgical Procedures | 1 | 2016 | 1489 | 0.070 |
Why?
|
Vasodilation | 3 | 2007 | 962 | 0.070 |
Why?
|
Carotid Stenosis | 1 | 2014 | 860 | 0.070 |
Why?
|
Ligation | 2 | 2004 | 448 | 0.070 |
Why?
|
Area Under Curve | 3 | 2017 | 1638 | 0.070 |
Why?
|
Neoplasms | 2 | 2012 | 22173 | 0.070 |
Why?
|
ROC Curve | 4 | 2017 | 3578 | 0.070 |
Why?
|
Rest | 3 | 2007 | 918 | 0.070 |
Why?
|
Defibrillators, Implantable | 1 | 2016 | 1490 | 0.070 |
Why?
|
Inflammation | 3 | 2016 | 10774 | 0.070 |
Why?
|
Heterocyclic Compounds | 1 | 2007 | 246 | 0.070 |
Why?
|
Heart Neoplasms | 1 | 2010 | 362 | 0.070 |
Why?
|
Surgery, Computer-Assisted | 1 | 2014 | 1007 | 0.070 |
Why?
|
Exercise | 2 | 2020 | 5890 | 0.060 |
Why?
|
Advisory Committees | 1 | 2010 | 787 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 5 | 2015 | 6484 | 0.060 |
Why?
|
Retinal Diseases | 2 | 2012 | 705 | 0.060 |
Why?
|
Cerebrospinal Fluid | 1 | 2009 | 544 | 0.060 |
Why?
|
Recovery of Function | 4 | 2019 | 2979 | 0.060 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2012 | 555 | 0.060 |
Why?
|
Myocardial Stunning | 1 | 2005 | 66 | 0.060 |
Why?
|
Laser Therapy | 2 | 2004 | 1092 | 0.060 |
Why?
|
Motion | 1 | 1989 | 779 | 0.060 |
Why?
|
Sleep Apnea Syndromes | 1 | 2014 | 975 | 0.060 |
Why?
|
Electrodes | 2 | 2014 | 614 | 0.060 |
Why?
|
Polylysine | 2 | 1996 | 131 | 0.060 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2006 | 352 | 0.060 |
Why?
|
Blood Glucose | 3 | 2016 | 6391 | 0.060 |
Why?
|
Comorbidity | 2 | 2017 | 10508 | 0.060 |
Why?
|
Information Storage and Retrieval | 1 | 2010 | 819 | 0.060 |
Why?
|
Societies, Medical | 2 | 2022 | 3905 | 0.060 |
Why?
|
Coronary Restenosis | 1 | 2007 | 396 | 0.060 |
Why?
|
Constriction | 1 | 2004 | 168 | 0.060 |
Why?
|
Animal Experimentation | 1 | 2004 | 46 | 0.060 |
Why?
|
Mortality | 1 | 2016 | 2902 | 0.060 |
Why?
|
Pattern Recognition, Automated | 1 | 2010 | 997 | 0.060 |
Why?
|
Embolism | 1 | 2007 | 399 | 0.060 |
Why?
|
Neovascularization, Pathologic | 1 | 2014 | 2645 | 0.060 |
Why?
|
Absorbable Implants | 1 | 2006 | 338 | 0.060 |
Why?
|
Enalapril | 2 | 2017 | 312 | 0.060 |
Why?
|
Cohort Studies | 8 | 2017 | 41495 | 0.060 |
Why?
|
Respiration | 3 | 2019 | 1656 | 0.060 |
Why?
|
Equipment Design | 4 | 2014 | 3511 | 0.060 |
Why?
|
3-Iodobenzylguanidine | 1 | 2024 | 114 | 0.060 |
Why?
|
Radionuclide Imaging | 3 | 2024 | 1972 | 0.050 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 1222 | 0.050 |
Why?
|
Leadership | 2 | 2022 | 1385 | 0.050 |
Why?
|
Autopsy | 1 | 2007 | 1009 | 0.050 |
Why?
|
Consensus | 2 | 2022 | 3124 | 0.050 |
Why?
|
Tomography, Emission-Computed | 2 | 2012 | 1122 | 0.050 |
Why?
|
Fluoroscopy | 2 | 2004 | 947 | 0.050 |
Why?
|
Blood Volume | 4 | 1999 | 547 | 0.050 |
Why?
|
Troponin T | 2 | 2018 | 780 | 0.050 |
Why?
|
Waist Circumference | 2 | 2016 | 935 | 0.050 |
Why?
|
Diagnosis, Differential | 5 | 2017 | 12973 | 0.050 |
Why?
|
Subcutaneous Fat | 2 | 2015 | 393 | 0.050 |
Why?
|
Genetic Testing | 1 | 2015 | 3537 | 0.050 |
Why?
|
Ventricular Function | 1 | 2004 | 406 | 0.050 |
Why?
|
Radiation Dosage | 1 | 2010 | 1958 | 0.050 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2024 | 459 | 0.050 |
Why?
|
Infant | 7 | 2019 | 36193 | 0.050 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2009 | 1496 | 0.050 |
Why?
|
Tissue and Organ Harvesting | 1 | 2004 | 373 | 0.050 |
Why?
|
Diabetes Complications | 2 | 2006 | 1315 | 0.050 |
Why?
|
Entropy | 1 | 2022 | 210 | 0.050 |
Why?
|
Biophysical Phenomena | 1 | 2002 | 320 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2024 | 2009 | 0.050 |
Why?
|
Renin | 1 | 2023 | 641 | 0.050 |
Why?
|
Health Status | 1 | 2014 | 4077 | 0.050 |
Why?
|
Biophysics | 1 | 2002 | 380 | 0.050 |
Why?
|
Osteopontin | 1 | 2022 | 301 | 0.050 |
Why?
|
Troponin | 1 | 2004 | 502 | 0.050 |
Why?
|
Dilatation, Pathologic | 2 | 2015 | 527 | 0.040 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2013 | 1875 | 0.040 |
Why?
|
Anti-Retroviral Agents | 2 | 2020 | 1784 | 0.040 |
Why?
|
Logistic Models | 4 | 2016 | 13255 | 0.040 |
Why?
|
Angina Pectoris | 2 | 2018 | 959 | 0.040 |
Why?
|
Graft Survival | 2 | 2016 | 3820 | 0.040 |
Why?
|
Cryopreservation | 1 | 2005 | 728 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3246 | 0.040 |
Why?
|
Angina, Unstable | 2 | 2018 | 888 | 0.040 |
Why?
|
Lung Volume Measurements | 1 | 2001 | 375 | 0.040 |
Why?
|
Eicosapentaenoic Acid | 1 | 2024 | 561 | 0.040 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2003 | 451 | 0.040 |
Why?
|
Palliative Care | 2 | 2015 | 3598 | 0.040 |
Why?
|
Proinsulin | 1 | 2019 | 135 | 0.040 |
Why?
|
Cholesterol, HDL | 2 | 2016 | 1814 | 0.040 |
Why?
|
Receptors, Chemokine | 1 | 2022 | 652 | 0.040 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 3204 | 0.040 |
Why?
|
Equipment Failure Analysis | 2 | 2014 | 847 | 0.040 |
Why?
|
Venous Pressure | 1 | 2019 | 56 | 0.040 |
Why?
|
Arterial Occlusive Diseases | 1 | 2003 | 748 | 0.040 |
Why?
|
Cardiology | 1 | 2010 | 1656 | 0.040 |
Why?
|
Necrosis | 2 | 2017 | 1611 | 0.040 |
Why?
|
Prolapse | 1 | 2018 | 63 | 0.040 |
Why?
|
User-Computer Interface | 1 | 2005 | 1400 | 0.040 |
Why?
|
Hepatic Veins | 1 | 2019 | 112 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2016 | 22174 | 0.040 |
Why?
|
Chronic Disease | 4 | 2018 | 9319 | 0.040 |
Why?
|
Linoleic Acid | 1 | 2019 | 158 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13642 | 0.040 |
Why?
|
Growth Substances | 1 | 2000 | 768 | 0.040 |
Why?
|
Bicycling | 1 | 2019 | 177 | 0.040 |
Why?
|
Arachidonic Acid | 1 | 2019 | 427 | 0.040 |
Why?
|
Electromagnetic Fields | 1 | 1999 | 296 | 0.040 |
Why?
|
C-Peptide | 1 | 2019 | 440 | 0.040 |
Why?
|
Calcinosis | 1 | 2006 | 1469 | 0.040 |
Why?
|
RNA, Small Untranslated | 1 | 2018 | 77 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2013 | 6815 | 0.040 |
Why?
|
Recurrence | 3 | 2014 | 8466 | 0.040 |
Why?
|
Germany | 1 | 2019 | 875 | 0.040 |
Why?
|
Biopsy | 3 | 2016 | 6766 | 0.040 |
Why?
|
Esophageal Neoplasms | 1 | 2007 | 1654 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2017 | 4111 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 2019 | 1625 | 0.030 |
Why?
|
Monte Carlo Method | 1 | 2002 | 1258 | 0.030 |
Why?
|
Posture | 1 | 2001 | 957 | 0.030 |
Why?
|
Models, Theoretical | 2 | 2004 | 3575 | 0.030 |
Why?
|
Echo-Planar Imaging | 1 | 2001 | 663 | 0.030 |
Why?
|
Mathematics | 1 | 1998 | 707 | 0.030 |
Why?
|
Glucosides | 1 | 2021 | 512 | 0.030 |
Why?
|
Cost-Benefit Analysis | 2 | 2020 | 5493 | 0.030 |
Why?
|
Biomedical Research | 1 | 2011 | 3429 | 0.030 |
Why?
|
Cholesterol | 1 | 2004 | 2905 | 0.030 |
Why?
|
Oxyhemoglobins | 1 | 2016 | 211 | 0.030 |
Why?
|
Magnetite Nanoparticles | 1 | 1997 | 318 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2021 | 2231 | 0.030 |
Why?
|
Dextrans | 1 | 1997 | 574 | 0.030 |
Why?
|
Nephelometry and Turbidimetry | 1 | 2015 | 91 | 0.030 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2015 | 91 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2020 | 1186 | 0.030 |
Why?
|
Dipyridamole | 2 | 2008 | 140 | 0.030 |
Why?
|
Elastic Modulus | 1 | 2015 | 211 | 0.030 |
Why?
|
Simvastatin | 1 | 2017 | 346 | 0.030 |
Why?
|
Principal Component Analysis | 2 | 2008 | 945 | 0.030 |
Why?
|
Capillaries | 1 | 1998 | 755 | 0.030 |
Why?
|
Minnesota | 1 | 2015 | 338 | 0.030 |
Why?
|
Hydrochlorothiazide | 1 | 2014 | 94 | 0.030 |
Why?
|
Lung | 1 | 2012 | 10002 | 0.030 |
Why?
|
Survival Rate | 3 | 2014 | 12723 | 0.030 |
Why?
|
Benzhydryl Compounds | 1 | 2021 | 916 | 0.030 |
Why?
|
Models, Statistical | 1 | 2008 | 5079 | 0.030 |
Why?
|
Body Weight | 2 | 2015 | 4618 | 0.030 |
Why?
|
Nausea | 1 | 2016 | 679 | 0.030 |
Why?
|
Atrophy | 1 | 2018 | 1633 | 0.030 |
Why?
|
Wound Healing | 1 | 2004 | 2805 | 0.030 |
Why?
|
Fourier Analysis | 2 | 1995 | 441 | 0.030 |
Why?
|
Troponin I | 1 | 2017 | 651 | 0.030 |
Why?
|
Adipokines | 1 | 2015 | 310 | 0.030 |
Why?
|
Heart Bypass, Right | 1 | 2013 | 75 | 0.030 |
Why?
|
Atrial Function | 1 | 2013 | 99 | 0.030 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2014 | 189 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 2015 | 728 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2016 | 983 | 0.030 |
Why?
|
Single-Blind Method | 2 | 2007 | 1574 | 0.030 |
Why?
|
Odds Ratio | 2 | 2015 | 9647 | 0.030 |
Why?
|
Body Surface Area | 1 | 2012 | 197 | 0.030 |
Why?
|
Vena Cava, Superior | 1 | 2013 | 195 | 0.020 |
Why?
|
Lysosomal Storage Diseases | 1 | 2012 | 79 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 1999 | 1779 | 0.020 |
Why?
|
Permeability | 1 | 1994 | 723 | 0.020 |
Why?
|
Diuretics | 1 | 2014 | 610 | 0.020 |
Why?
|
Magnetics | 2 | 2010 | 599 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 21019 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2017 | 1301 | 0.020 |
Why?
|
Protein Precursors | 1 | 2015 | 1132 | 0.020 |
Why?
|
Hemoglobins | 1 | 2016 | 1526 | 0.020 |
Why?
|
Regression Analysis | 2 | 2011 | 6345 | 0.020 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2014 | 1435 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 3 | 2017 | 17904 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2007 | 6345 | 0.020 |
Why?
|
Morbidity | 1 | 2015 | 1752 | 0.020 |
Why?
|
Lipids | 2 | 2014 | 3341 | 0.020 |
Why?
|
Spirometry | 1 | 2012 | 929 | 0.020 |
Why?
|
Thermodilution | 1 | 2009 | 50 | 0.020 |
Why?
|
Creatinine | 1 | 2015 | 1899 | 0.020 |
Why?
|
Telemetry | 1 | 2010 | 199 | 0.020 |
Why?
|
Oximetry | 1 | 2012 | 459 | 0.020 |
Why?
|
Cardiotonic Agents | 1 | 2011 | 539 | 0.020 |
Why?
|
Primary Prevention | 1 | 2016 | 1186 | 0.020 |
Why?
|
Boston | 2 | 2011 | 9327 | 0.020 |
Why?
|
Brain | 1 | 1995 | 27121 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7237 | 0.020 |
Why?
|
Marfan Syndrome | 1 | 2010 | 236 | 0.020 |
Why?
|
Propensity Score | 1 | 2015 | 1913 | 0.020 |
Why?
|
Atrial Septum | 1 | 2008 | 60 | 0.020 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 1516 | 0.020 |
Why?
|
Water | 1 | 1994 | 1411 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2014 | 1889 | 0.020 |
Why?
|
Ultrasonography | 2 | 2016 | 5971 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2015 | 2382 | 0.020 |
Why?
|
Body Height | 1 | 2012 | 1570 | 0.020 |
Why?
|
Sampling Studies | 1 | 2007 | 615 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2018 | 4431 | 0.020 |
Why?
|
Radiography | 2 | 2009 | 6965 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2007 | 9032 | 0.020 |
Why?
|
Computer Systems | 1 | 2006 | 470 | 0.020 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2010 | 536 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 1995 | 2727 | 0.010 |
Why?
|
Survivors | 1 | 2015 | 2371 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 6312 | 0.010 |
Why?
|
Europe | 1 | 2010 | 3420 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 2004 | 659 | 0.010 |
Why?
|
Graft Rejection | 1 | 2016 | 4446 | 0.010 |
Why?
|
Plaque, Atherosclerotic | 1 | 2014 | 1532 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2014 | 4352 | 0.010 |
Why?
|
Heart Septum | 1 | 2004 | 301 | 0.010 |
Why?
|
Fever | 1 | 2010 | 1618 | 0.010 |
Why?
|
Lung Diseases | 1 | 2012 | 1909 | 0.010 |
Why?
|
Dyspnea | 1 | 2010 | 1347 | 0.010 |
Why?
|
MicroRNAs | 1 | 2018 | 3816 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7828 | 0.010 |
Why?
|
Retina | 1 | 2012 | 2659 | 0.010 |
Why?
|
Probability | 1 | 2007 | 2477 | 0.010 |
Why?
|
Fibrin | 1 | 2004 | 507 | 0.010 |
Why?
|
Movement | 1 | 2008 | 1478 | 0.010 |
Why?
|
Pain Measurement | 1 | 2012 | 3551 | 0.010 |
Why?
|
Transduction, Genetic | 1 | 2004 | 903 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8833 | 0.010 |
Why?
|
Mesoderm | 1 | 2004 | 674 | 0.010 |
Why?
|
Insulin | 1 | 2015 | 6597 | 0.010 |
Why?
|
Thallium Radioisotopes | 1 | 2001 | 138 | 0.010 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2003 | 506 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15936 | 0.010 |
Why?
|
Patient Selection | 1 | 2012 | 4244 | 0.010 |
Why?
|
Macrophages | 1 | 2014 | 5767 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2004 | 2115 | 0.010 |
Why?
|
Least-Squares Analysis | 1 | 2000 | 369 | 0.010 |
Why?
|
Myoglobin | 1 | 1999 | 159 | 0.010 |
Why?
|
Phosphocreatine | 1 | 1999 | 261 | 0.010 |
Why?
|
Health Care Costs | 1 | 2011 | 3242 | 0.010 |
Why?
|
Catheterization | 1 | 2003 | 1428 | 0.010 |
Why?
|
Kidney | 1 | 2012 | 7048 | 0.010 |
Why?
|
Drug Residues | 1 | 1996 | 7 | 0.010 |
Why?
|
Preoperative Care | 1 | 2005 | 2242 | 0.010 |
Why?
|
Models, Animal | 1 | 2003 | 2112 | 0.010 |
Why?
|
Prostheses and Implants | 1 | 2003 | 1271 | 0.010 |
Why?
|
Dobutamine | 1 | 1996 | 116 | 0.010 |
Why?
|
Stents | 1 | 2007 | 3179 | 0.010 |
Why?
|
Nanoparticles | 1 | 2007 | 1958 | 0.010 |
Why?
|
Phosphates | 1 | 1999 | 770 | 0.010 |
Why?
|
Risk | 1 | 2007 | 9610 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 1999 | 1989 | 0.010 |
Why?
|
Cell Movement | 1 | 2004 | 5205 | 0.010 |
Why?
|
Specimen Handling | 1 | 1996 | 702 | 0.010 |
Why?
|
Stem Cells | 1 | 2004 | 3524 | 0.010 |
Why?
|
Drug Combinations | 1 | 1997 | 2048 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2011 | 26202 | 0.010 |
Why?
|
Ultrasonography, Interventional | 1 | 1997 | 1496 | 0.010 |
Why?
|
Stroke | 1 | 2011 | 9758 | 0.000 |
Why?
|
Cells, Cultured | 1 | 2004 | 18966 | 0.000 |
Why?
|
Kinetics | 1 | 1995 | 6374 | 0.000 |
Why?
|
Cell Differentiation | 1 | 2004 | 11530 | 0.000 |
Why?
|